Literature DB >> 17264427

Insulin resistance in chronic hepatitis B and C.

Amir Houshang Mohammad Alizadeh1, Farahnaz Fallahian, Seyed Moayed Alavian, Mitra Ranjbar, Mehdi Hedayati, Farzaneh Rahimi, Hossein Khedmat, Arash Etemadi, Mohammad Reza Zali, Fereidoun Azizi.   

Abstract

AIM: To determine whether insulin resistance occurs in patients with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) and its relationship with the presence of liver fibrosis and steatosis.
METHODS: Untreated patients with CHC (n=60) or CHB (n=40), similar in age, gender, body mass index and waist-hip ratio, were studied. Relationship between anthropometric, biochemical (fasting serum insulin, C-peptide, ferritin, iron, TNF-alpha, cholesterol, triglyceride, bilirubin, hemoglobin and platelet concentrations) and liver biopsy (43 CHC and 20 CHB patients) findings was investigated by insulin resistance determined via the homeostasis model assessment (HOMA-IR).
RESULTS: The mean fasting serum insulin was 14.9 (11.9) mU/mL in CHC and 21.4 (17.4) in the CHB group (normal range 0.7-9; p=0.049) and mean HOMA-IR was 3.1 (2.6) in CHC versus 4.7 (4.1) in the CHB group (normal range 0.12-4.61; p=0.036). HOMA-IR was significantly associated with fibrosis stage in the CHC group (p=0.015), but not in the CHB group.
CONCLUSION: Hyperinsulinemia occurs in chronic viral hepatitis B and hepatitis C; insulin resistance is associated with stage of fibrosis in hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17264427

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  5 in total

1.  Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3.

Authors:  KyeongJin Kim; Kook Hwan Kim; JaeHun Cheong
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

2.  Association of chronic viral hepatitis B with insulin resistance.

Authors:  Jeong Gyu Lee; Sangyeoup Lee; Yun Jin Kim; Byung Mann Cho; Joo Sung Park; Hyung Hoi Kim; Jaehun Cheong; Dong Wook Jeong; Yu Hyun Lee; Young Hye Cho; Mi Jin Bae; Eun Jung Choi
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 3.  Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.

Authors:  Ichiro Shimizu; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Hui-Wei Huang; Jiang-Hong He; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

4.  To study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease.

Authors:  Harpreet Kaur; Parminder Singh; Harminder Singh Pannu; Ajit Sood; Narender Pal Jain; Harpreet Singh Bhoday
Journal:  J Clin Diagn Res       Date:  2015-03-01

5.  Herbal medicine and liver disease, for any conclusion we need to do more studies.

Authors:  Seyed Moayed Alavian
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.